VTGN Earnings Vistagen Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| FY 2026 | 2026-03-31 | -1.83 | 2026-06-15 | 10-K |
| Q3 2026 | 2025-12-31 | -1.46 | 2026-02-12 | 10-Q |
| Q2 2026 | 2025-09-30 | -1.02 | 2025-11-13 | 10-Q |
| Q1 2026 | 2025-06-30 | -0.47 | 2025-08-07 | 10-Q |
| FY 2026 | 2025-03-31 | -1.67 | 2026-06-15 | 10-K |
| Q3 2026 | 2024-12-31 | -1.23 | 2026-02-12 | 10-Q |
| Q2 2026 | 2024-09-30 | -0.77 | 2025-11-13 | 10-Q |
| Q1 2026 | 2024-06-30 | -0.35 | 2025-08-07 | 10-Q |
| FY 2025 | 2024-03-31 | -1.52 | 2025-06-17 | 10-K |
| Q3 2025 | 2023-12-31 | -1.27 | 2025-02-13 | 10-Q |
| Q2 2025 | 2023-09-30 | -1.55 | 2024-11-07 | 10-Q |
| Q1 2025 | 2023-06-30 | -0.94 | 2024-08-13 | 10-Q |
| FY 2024 | 2023-03-31 | -8.51 | 2024-06-11 | 10-K |
| FY 2016 | 2016-03-31 | -29.08 | 2016-06-24 | 10-K |
| Q3 2016 | 2015-12-31 | -25.45 | 2016-02-16 | 10-Q |
| Q2 2016 | 2015-09-30 | -24.21 | 2015-11-16 | 10-Q |
| FY 2016 | 2015-03-31 | -10.61 | 2016-06-24 | 10-K |
| FY 2016 | 2014-12-31 | -1.08 | 2016-06-24 | 10-K |
| FY 2016 | 2014-09-30 | -1.90 | 2016-06-24 | 10-K |
| FY 2016 | 2014-06-30 | -3.70 | 2016-06-24 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.